Parmax Pharma informs about disclosure
Date: 02-09-2026Parmax Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Shah & PACs.
The above information is a part of company’s filings submitted to BSE.